FPC
TNDM icon

Falcon Point Capital’s Tandem Diabetes Care TNDM Stock Holding History

Falcon Point Capital’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-26,141
Closed -$209K – 120
2017
Q2 		$209K Buy
26,141
+37
+0.1% +$342 0.03% 107
2017
Q1 		$313K Buy
+26,104
New +$571K 0.04% 104

Other funds holding TNDM

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Falcon Point Capital's TNDM Position: Q3 2017 in Review

Falcon Point Capital sold out of Tandem Diabetes Care (TNDM) in Q3 2017, closing a stake of 26,141 shares — an estimated $209K sold.

Falcon Point Capital first reported a position in TNDM in Q1 2017 and held it in 2 quarters. The position peaked at $313K in Q1 2017. 46 funds tracked by Wall St. Rank hold TNDM as of Q3 2017.

  • Falcon Point Capital reported no remaining Tandem Diabetes Care position as of Q3 2017 after selling out during the quarter.
  • Falcon Point Capital sold 26,141 Tandem Diabetes Care shares in Q3 2017, an estimated $209K.
  • Falcon Point Capital first reported a position in Tandem Diabetes Care in Q1 2017 and held it in 2 quarters.
  • Falcon Point Capital's Tandem Diabetes Care position peaked at $313K in Q1 2017.
  • 46 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2017.

Based on Falcon Point Capital's 13F filing for Q3 2017, filed 14 Nov 2017.